Inactive Instrument

Avivagen Inc. Stock Toronto S.E.

VIV.H

CA05382F2026

Avivagen Inc. is a Canada-based life sciences company. The Company is focused on developing and commercializing products for livestock, companion animal and human applications that enhances feed intake and supports immune function, thereby supporting general health and performance. The Companyâ€™s operations as one segment, products based on OxC-beta Technology. Its OxC-beta technology is derived from its discoveries about B-carotene and other carotenoids, compounds that give certain fruits and vegetables their bright colors. OxC- beta Livestock is a product, an alternative to the antibiotics commonly added to livestock feeds. The product is available for sale in the United States, Mexico, Philippines, Taiwan, New Zealand, Thailand, Australia and Malaysia.

Employees

Sector

Fishing & Farming

More about the company

Google lets you customize your preferred sources.

Choose MarketScreener

Market Cap	591K 519K 481K 443K 836K 56.5M 854K 5.74M 2.25M 27.77M 2.22M 2.17M 95.99M	P/E 2021	-3.05x	P/E 2022	-1.52x
Enterprise Value	6.39M 5.61M 5.2M 4.78M 9.04M 611M 9.23M 62.02M 24.29M 300M 23.98M 23.45M 1.04B	EV / Sales 2021	20.5x	EV / Sales 2022	17.7x
Free-Float	98.89%	Yield 2021 *	-	Yield 2022	-

24-04-24	Avivagen Makes Voluntary Assignment into Bankruptcy Under the BIA	NE
21-04-06	Avivagen Discusses Significant Purchase Orders for OxC-beta(TM) Livestock with The Stock Day Podcast	NE
20-07-23	Avivagen: The OxC-beta(TM) Technology Is A True Game Changer	NE
19-10-02	Avivagen Inc. CEO, Kym Anthony, Joins The Stock Day Podcast to Discuss Their Expansion Strategy	NE
18-05-01	Avivagen Announces its Attendance at the Bloom Burton & Co. Healthcare Investor Conference	GL

Manager	Title	Age	Since
G. Anthony CEO	Chief Executive Officer	70	2017-02-08
Ira Levy DFI	Director of Finance/CFO	-	-
Drew Basek IRC	Investor Relations Contact	-	2017-02-28

Director	Title	Age	Since
David Hankinson CHM	Chairman	-	2005-08-03
G. Anthony CHM	Chairman	70	2014-07-24
Paul Mesburis BRD	Director/Board Member	56	2016-04-04

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
AVIVAGEN INC.	-.--%	-.--%	-	-	77
GUANGDONG HAID GROUP CO., LIMITED	-0.51%	-1.56%	-20.75%	-7.38%	10.81B
NEW HOPE LIUHE CO.,LTD.	-1.40%	+3.83%	-28.16%	-39.98%	4.71B
PT CHAROEN POKPHAND INDONESIA TBK	0.00%	+1.30%	-36.84%	-42.75%	2.83B
AKTIESELSKABET SCHOUW & CO.	+1.13%	+2.97%	+1.63%	+14.05%	2.14B
BEIJING DABEINONG TECHNOLOGY GROUP CO.,LTD.	-0.33%	+3.10%	-28.12%	-56.09%	1.89B
AVANTI FEEDS LIMITED	+2.76%	-0.68%	+27.48%	+133.82%	1.32B
FUJIAN AONONG BIOLOGICAL TECHNOLOGY GROUP INCORPORATION LIMITED	-2.38%	-0.35%	-23.26%	-69.30%	1.18B
FUJIAN TIANMA SCIENCE AND TECHNOLOGY GROUP CO., LTD	-3.85%	-9.54%	-11.35%	-11.57%	891M
GUANGDONG YUEHAI FEEDS GROUP CO.,LTD.	-10.00%	-6.18%	-8.88%	-14.34%	833M
Average	-1.46%	-2.96%	-14.25%	-10.39%	2.96B
Weighted average by Cap.	-0.80%	-3.59%	-19.54%	-14.77%

Avivagen Inc. Stock Toronto S.E.

Stocks

VIV.H

CA05382F2026

Fishing & Farming

Valuation: Avivagen Inc.

Press Releases: Avivagen Inc.

Managers and Directors: Avivagen Inc.

Animal Feed

Financials

Company Profile

	2021	2022
Net sales	1.3M 1.14M 1.06M 971K 1.83M 124M 1.87M 12.59M 4.93M 60.89M 4.87M 4.76M 211M	939K 825K 765K 704K 1.33M 89.8M 1.36M 9.12M 3.57M 44.13M 3.53M 3.45M 153M
Net income	-6.39M -5.62M -5.21M -4.79M -9.05M -611M -9.24M -62.1M -24.32M -300M -24.01M -23.48M -1.04B	-6.07M -5.33M -4.94M -4.54M -8.58M -580M -8.77M -58.92M -23.07M -285M -22.78M -22.28M -985M
Net Debt	5.4M 4.74M 4.4M 4.04M 7.64M 516M 7.81M 52.43M 20.53M 254M 20.27M 19.83M 877M	5.8M 5.09M 4.72M 4.34M 8.2M 554M 8.38M 56.29M 22.04M 272M 21.76M 21.28M 941M